Silexion Therapeutics (SLXN) Current Leases (2023 - 2026)
Silexion Therapeutics (SLXN) posted quarterly Current Leases of $185000.0 for Q1 2026, up 19.35% year-over-year from $155000.0 in Q1 2025, and up 1.65% quarter-over-quarter from $182000.0 in Q4 2025.
Silexion Therapeutics (SLXN) Current Leases (2023 - 2026) Analysis & Trends
Silexion Therapeutics' Current Leases history runs 4 years deep, the most recent figure standing at $185000.0 for Q1 2026.
- In Q1 2026, Current Leases rose 19.35% year-over-year to $185000.0; the TTM figure through Mar 2026 stood at $185000.0 (up 19.35% YoY), while the FY2025 annual figure was $182000.0, up 15.19% from the prior year.
- Current Leases for Q1 2026 stood at $185000.0, up from $182000.0 in the prior quarter.
- The five-year high for Current Leases was $185000.0 in Q1 2026, with the low at $108000.0 in Q2 2024.
- The 4-year median for Current Leases is $164500.0 (2024), against an average of $155625.0.
- Peak annual rise in Current Leases reached 58.33% in 2025, while the deepest fall reached 15.19% in 2025.
- Silexion Therapeutics' Current Leases stood at $112000.0 in 2023, then soared by 41.07% to $158000.0 in 2024, then rose by 15.19% to $182000.0 in 2025, then rose by 1.65% to $185000.0 in 2026.
- Business Quant data shows SLXN's Current Leases at $185000.0 in Q1 2026, $182000.0 in Q4 2025, and $174000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Silexion Therapeutics | 266,692.97 | -1.96 Mn | - | 199,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 199,000.00 |
| Mar 31, 2026 | 185,000.00 |
| Dec 31, 2025 | 182,000.00 |
| Sep 30, 2025 | 174,000.00 |
| Jun 30, 2025 | 171,000.00 |
| Mar 31, 2025 | 155,000.00 |
| Dec 31, 2024 | 158,000.00 |
| Jun 30, 2024 | 108,000.00 |
| Dec 31, 2023 | 112,000.00 |